Corporate Profile
About ResMed

ResMed (NYSE: RMD and ASX: RMD.AX) is a leading developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. The company is dedicated to developing innovative products to improve ... More >>

Receive E-mail AlertsE-mail Alert Icon
Alerts are e-mailed to you whenever certain new company information is posted to this site.
Sign-up Now!
Recent Event
ResMed Inc. at Deutsche Bank AG Health Care Conference
Tuesday, May 8, 2012 10:00 a.m. ET
Stock Quote
ExchangeNYSE (US Dollar)
Price$33.21
Change (%) Stock is Down 0.82 (2.41%)
Volume1,287,200
Data as of 05/16/12 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Presentations
DateTitle
04/26/12
Q3 2012 Investor Presentation
01/26/12
Q2 2012 Investor Presentation
10/27/11
Q1 2012 Investor Presentation
08/11/11
Q4 2011 Investor Presentation
04/29/11
Q3 2011 Investor Presentation
01/31/11
Q2 2011 Investor Presentation
10/28/10
Q1 2011 Investor Presentation
09/02/10
Q4 2010 Investor Presentation
04/29/10
Q3 2010 Investor Presentation
Recent NewsMore >>
DateTitle 
04/26/12ResMed Inc. Announces Record Financial Results For The Quarter Ended And Nine Months Ended March 31, 2012
SAN DIEGO, April 26, 2012 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced record revenue and income for the quarter ended March 31, 2012.  Revenue for the quarter ended March 31, 2012 was $349.1 million, an 11% increase (a 13% increase on a constant currency basis) over the quarter ended March 31, 2011.  For the quarter ended March 31, 2012, income from operations was $76.5 million and net income was $64.6 million, an increase of 20% and 21%, respectively, compared to the quarter ended... 
Printer Friendly Version
04/11/12ResMed Announces EasyCare Online Compliance Management Solution
ResMed's new cloud-based system lets customers access patient compliance anywhere with an internet connection SAN DIEGO, April 11, 2012 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced the release of its new patient compliance management solution, EasyCare Online. The innovative new tool aggregates usage and efficacy data from obstructive sleep apnea patients who use continuous positive airway pressure (CPAP) treatment. The data can be used by sleep labs, home medical equipment and oth... 
Printer Friendly Version
03/26/12ResMed Announces Conference Call and Webcast to Discuss Third Quarter 2012 Results
SAN DIEGO, March 26, 2012 /PRNewswire/ -- RESMED INC. (NYSE: RMD), announced today that on Thursday, April 26, 2012, it will release its results for the third quarter and nine months of fiscal year 2012, ended March 31, 2012. A press release with ResMed's results will be issued after 1:00 p.m. Pacific Time and the company will host a conference call and webcast to review its results, market trends, and future outlook. (Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO) The co... 
Printer Friendly Version
03/07/12Resmed Inc. to Present at Upcoming Conferences
SAN DIEGO, March 7, 2012 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) announced today that it will be presenting at four upcoming conferences: (Logo:  http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO) Barclays Capital Global Healthcare Conference at the Loews Miami Hotel in Miami, FL on March 14, 2012; Deutsche Health Care Conference at the InterContinental Hotel in Boston, MA on May 8, 2012; Wm. Blair Healthcare Conference at the Four Seasons in Chicago, IL on June 14, 2012; an... 
Printer Friendly Version
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.


Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet

©2000-2008 ResMed. All rights reserved.